INSPIRA™ ART100 Completes Usability Study in Boston Massachusetts, U.S.
- Inspira Technologies aims to revolutionize acute respiratory care
- High-grade technology could disrupt the medical device industry
- None.
RA'ANANA,
The Usability Study included
Dagi Ben Noon, Inspira Technologies' Chief Executive Officer, stated: "We are advancing with the INSPIRA ART100. We plan to take a position in disrupting the medical device industry with our high-grade technology."
The INSPIRA ART100 is an extracorporeal blood circulation medical device designed for cardiac and pulmonary support, by providing continuous enrichment of the blood with oxygen and carbon dioxide removal. The INSPIRA ART100 may be suitable for a wide range of extracorporeal treatments in the ICU and during heart surgery.
About Inspira Technologies OXY B.H.N. Ltd.
Inspira Technologies has a clear mission to revolutionize acute respiratory care through innovation. Our aim is to develop medical technologies and products that prevent the need for mechanical ventilation. Empowering breathing without lungs, the flagship INSPIRA™ ART500 is designed to boost blood oxygen saturation levels in a matter of minutes, even as the patient remains awake. We strive to deliver blood circulation technology alongside AI driven monitoring and analytics to create patient-centric and data-driven solutions that enhance patient outcome and improve hospital efficiency. Through our continuous efforts, we aim to reshape the future of extracorporeal treatments to create a better healthcare experience for patients around the world. The Company's products have not yet been tested or used in humans and have not been approved by any regulatory entity.
For more information, please visit our corporate website:
https://inspira-technologies.com
Forward-Looking Statement Disclaimer
This press release contains express or implied forward-looking statements pursuant to
For more details:
Public Relations Manager
Adi Shmueli
Inspira Technologies
info@inspirao2.com
+972-9-9664485
Copyright © 2018-2023 Inspira Technologies OXY B.H.N. LTD., All rights reserved.
Logo - https://mma.prnewswire.com/media/1941810/Inspira_Technologies_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/inspira-art100-completes-usability-study-in-boston-massachusetts-us-301896792.html
SOURCE Inspira Technologies